US heavyweights line up on Bayer’s $14.2bn Merck deal

Sullivan & Cromwell, Fried Frank Harris Shriver & Jacobson and Morgan Lewis & Bockius have taken the lead roles on German pharmaceuticals firm Bayer's $14.2bn acquisition of US rival Merck's consumer care business.

Sullivan & Cromwell, Fried Frank Harris Shriver & Jacobson and Morgan Lewis & Bockius have taken the lead roles on German pharmaceuticals firm Bayer’s $14.2bn (£8.4bn) acquisition of US rival Merck’s consumer care business.

The deal is the latest in a series of blockbuster mandates for the pharma industry, and follows Pfizer’s £63bn approach for AstraZeneca, which would be the largest takeover of a UK listed company in history.

This premium content is reserved for
Legal Week Subscribers.

Subscribe today to get ALL ACCESS and 15% off!

A premium subscription gives you access to all articles and provides:

  • Trusted insight, news and analysis from the UK and across the globe
  • Connections to senior business lawyers within the leading law firms and legal departments
  • Unique access to ALM’s unrivalled, market-leading reporting in the US and Asia and cutting-edge research, including Legal Week’s UK Top 50 and Global 100 rankings
  • The Legal Week Daily News Alert, Editor’s Highlights, and Breaking News digital newsletters and more, plus a choice of over 70 ALM newsletters
  • Optimized access on all of your devices: desktop, tablet and mobile
  • Complete access to the site’s full archive of more than 56,000 articles

Subscribe Now For All Access

For enterprise-wide or corporate enquiries, please contact Paul Reeves on Preeves@alm.com or call on +44 (0) 203 875 0651